Walter H. Moos, Ph.D. joined us as a director in March 1997. Since October 2018 Dr. Moos has worked at Pandect venture capital firms, including Pandect Bioventures where he is a Managing Director, and Pandect Catalyst where he is a Managing Member, investing in life sciences (therapeutics, diagnostics, medical devices, agriculture, biotechnology), cleantech (clean air, clean water, energy storage), and sensors. Dr. Moos also serves on the boards of directors of Valitor, Inc., Circle Pharma, Inc., and Organos, Inc. From February 2017 to June 2020, Dr. Moos was Chief Executive Officer of ShangPharma Innovation, Inc., a global pharmaceutical incubator investing in therapeutics and biotechnologies, where he served as Chairman Emeritus from December 2020 to January 2023. He retired from his position as President of SRI Biosciences in 2016 after more than a decade at the independent nonprofit SRI International (Stanford Research Institute). From 1997 to 2004, Dr. Moos served as Chairman and Chief Executive Officer of MitoKor, Inc., which became the biopharmaceutical company MIGENIX, Inc., where he was a member of the board of directors from 2004 to 2008. Prior to that, he served as a Vice President of Chiron Corp. (now Novartis), and as a Vice President at the Parke-Davis Pharmaceutical Research Division of the Warner-Lambert Co. (now Pfizer). He has been an adjunct Professor at the University of California, San Francisco since 1992. He has also served on the boards of numerous private companies and several non-profit organizations, including Keystone Symposia (from 2002-2011 and again since 2014), and has been an advisor to a wide range of organizations in the U.S. and around the world. Dr. Moos holds an A.B. from Harvard University and a Ph.D. in Chemistry from the University of California Berkeley.
What is Walter H. Moos' net worth?
The estimated net worth of Walter H. Moos is at least $326.06 thousand as of February 20th, 2026. Moos owns 12,722 shares of Rigel Pharmaceuticals stock worth more than $326,065 as of March 24th. This net worth evaluation does not reflect any other investments that Moos may own. Learn More about Walter H. Moos' net worth.
How do I contact Walter H. Moos?
Has Walter H. Moos been buying or selling shares of Rigel Pharmaceuticals?
Over the course of the past ninety days, Walter H. Moos has sold $145,440.00 in shares of Rigel Pharmaceuticals stock. Most recently, Walter H. Moos sold 4,000 shares of the business's stock in a transaction on Friday, February 20th. The shares were sold at an average price of $36.36, for a transaction totalling $145,440.00. Following the completion of the sale, the director now directly owns 12,722 shares of the company's stock, valued at $462,571.92. Learn More on Walter H. Moos' trading history.
Who are Rigel Pharmaceuticals' active insiders?
Are insiders buying or selling shares of Rigel Pharmaceuticals?
In the last twelve months, insiders at the biotechnology company sold shares 1 times. They sold a total of 4,000 shares worth more than $145,440.00. The most recent insider tranaction occured on February, 20th when Director Walter H Moos sold 4,000 shares worth more than $145,440.00. Insiders at Rigel Pharmaceuticals own 9.5% of the company.
Learn More about insider trades at Rigel Pharmaceuticals. Information on this page was last updated on 2/20/2026.
